Stocktoria
iSpecimen Inc. ISPC
Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-06-17
iSpecimen Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $9.3M | $9.9M | $10.4M | $11.1M | $8.2M |
| R&D expense | — | $1.5M | $1.6M | $1.5M | $879,243 | $319,235 |
| Operating income | -$9.0M | -$12.7M | -$11.2M | -$10.2M | -$5.9M | -$2.4M |
| Interest expense | — | — | $16,001 | $238,963 | $2.1M | $2.1M |
| Income tax | — | — | $0 | $0 | $0 | $0 |
| Net income | -$10.5M | -$12.5M | -$11.1M | -$10.2M | -$9.0M | -$4.7M |
| EPS (diluted) | $-2.28 | $-17.58 | $-24.55 | $-1.16 | $-2.09 | $-4.97 |
| Operating cash flow | -$4.2M | -$8.3M | -$5.8M | -$5.8M | -$10.7M | -$288,380 |
| Free cash flow | -$4.2M | -$8.3M | -$5.8M | -$6.0M | -$10.7M | -$288,806 |
| Cash & equivalents | $6.9M | $1.9M | $2.3M | $15.3M | $27.7M | $695,909 |
| Inventory | — | $45,110 | — | — | — | — |
| Total assets | $9.5M | $9.4M | $15.8M | $24.6M | $35.7M | $6.2M |
| Total liabilities | $6.4M | $6.0M | $6.1M | $4.3M | $5.9M | $22.3M |
| Shareholders' equity | $3.1M | $3.3M | $9.7M | $20.3M | $29.8M | -$27.3M |
Growth · year-over-year · Revenue CAGR -25.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -79.2% | -6.4% | -4.6% | -6.6% | +36.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.